Regenerative medicine of pancreatic islets

被引:15
作者
Arutyunyan, Irina, V [1 ]
Fatkhudinov, Timur Kh [2 ,3 ]
Makarov, Andrey, V [1 ,4 ]
Elchaninov, Andrey, V [1 ]
Sukhikh, Gennady T. [1 ]
机构
[1] Natl Med Res Ctr Obstet Gynecol & Perinatol, Moscow 117997, Russia
[2] Res Inst Human Morphol, Moscow 117418, Russia
[3] Peoples Friendship Univ Russia, Moscow 117198, Russia
[4] Pirogov Russian Natl Res Med Univ, Minist Healthcare Russian Federat, Moscow 117997, Russia
关键词
Pancreas; Islets of langerhans; beta-cells; Regeneration; Replacement; Transplantation; Reprogramming; BETA-CELL MASS; INSULIN-PRODUCING CELLS; TYPE-2; DIABETES-MELLITUS; INCRETIN-BASED THERAPIES; MESENCHYMAL STEM-CELLS; BONE-MARROW; EXOCRINE CELLS; GROWTH-FACTOR; ADULT-MOUSE; PROGENITOR CELLS;
D O I
10.3748/wjg.v26.i22.2948
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The pancreas became one of the first objects of regenerative medicine, since other possibilities of dealing with the pancreatic endocrine insufficiency were clearly exhausted. The number of people living with diabetes mellitus is currently approaching half a billion, hence the crucial relevance of new methods to stimulate regeneration of the insulin-secreting beta-cells of the islets of Langerhans. Natural restrictions on the islet regeneration are very tight; nevertheless, the islets are capable of physiological regenerationvia beta-cell self-replication, direct differentiation of multipotent progenitor cells and spontaneous alpha- to beta- or delta- to beta-cell conversion (trans-differentiation). The existing preclinical models of beta-cell dysfunction or ablation (induced surgically, chemically or genetically) have significantly expanded our understanding of reparative regeneration of the islets and possible ways of its stimulation. The ultimate goal, sufficient level of functional activity of beta-cells or their substitutes can be achieved by two prospective broad strategies: beta-cell replacement and beta-cell regeneration. The "regeneration" strategy aims to maintain a preserved population of beta-cells throughin situexposure to biologically active substances that improve beta-cell survival, replication and insulin secretion, or to evoke the intrinsic adaptive mechanisms triggering the spontaneous non-beta- to beta-cell conversion. The "replacement" strategy implies transplantation of beta-cells (as non-disintegrated pancreatic material or isolated donor islets) or beta-like cells obtainedex vivofrom progenitors or mature somatic cells (for example, hepatocytes or alpha-cells) under the action of small-molecule inducers or by genetic modification. We believe that the huge volume of experimental and clinical studies will finally allow a safe and effective solution to a seemingly simple goal-restoration of the functionally active beta-cells, the innermost hope of millions of people globally.
引用
收藏
页码:2948 / 2966
页数:19
相关论文
共 143 条
  • [1] Differentiation of human pluripotent stem cells into two distinct NKX6.1 populations of pancreatic progenitors
    Aigha, Idil I.
    Memon, Bushra
    Elsayed, Ahmed K.
    Abdelalim, Essam M.
    [J]. STEM CELL RESEARCH & THERAPY, 2018, 9
  • [2] The Potential of South African Herbal Tisanes, Rooibos and Honeybush in the Management of Type 2 Diabetes Mellitus
    Ajuwon, Olawale R.
    Ayeleso, Ademola O.
    Adefolaju, Gbenga A.
    [J]. MOLECULES, 2018, 23 (12):
  • [3] Reprogramming of pancreatic exocrine cells towards a beta (β) cell character using Pdx1, Ngn3 and MafA
    Akinci, Ersin
    Banga, Anannya
    Greder, Lucas V.
    Dutton, James R.
    Slack, Jonathan M. W.
    [J]. BIOCHEMICAL JOURNAL, 2012, 442 : 539 - 550
  • [4] Reprogrammed Stomach Tissue as a Renewable Source of Functional β Cells for Blood Glucose Regulation
    Ariyachet, Chaiyaboot
    Tovaglieri, Alessio
    Xiang, Guanjue
    Lu, Jiaqi
    Shah, Manasvi S.
    Richmond, Camilla A.
    Verbeke, Catia
    Melton, Douglas A.
    Stanger, Ben Z.
    Mooney, David
    Shivdasani, Ramesh A.
    Mahony, Shaun
    Xia, Qing
    Breault, David T.
    Zhou, Qiao
    [J]. CELL STEM CELL, 2016, 18 (03) : 410 - 421
  • [5] Using Mesenchymal Stromal Cells in Islet Transplantation
    Arzouni, Ahmed A.
    Vargas-Seymour, Andreia
    Nardi, Nance
    King, Aileen J. F.
    Jones, Peter M.
    [J]. STEM CELLS TRANSLATIONAL MEDICINE, 2018, 7 (08) : 559 - 563
  • [6] Growth factor control of pancreatic islet regeneration and function
    Assmann, Anke
    Hinault, Charlotte
    Kulkarni, Rohit N.
    [J]. PEDIATRIC DIABETES, 2009, 10 (01) : 14 - 32
  • [7] Reversal of experimental diabetes by multiple bone marrow transplantation
    Banerjee, M
    Kumar, A
    Bhonde, RR
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 328 (01) : 318 - 325
  • [8] Barkai Uriel, 2016, World J Transplant, V6, P69, DOI 10.5500/wjt.v6.i1.69
  • [9] Improvement in Outcomes of Clinical Islet Transplantation: 1999-2010
    Barton, Franca B.
    Rickels, Michael R.
    Alejandro, Rodolfo
    Hering, Bernhard J.
    Wease, Stephen
    Naziruddin, Bashoo
    Oberholzer, Jose
    Odorico, Jon S.
    Garfinkel, Marc R.
    Levy, Marlon
    Pattou, Francois
    Berney, Thierry
    Secchi, Antonio
    Messinger, Shari
    Senior, Peter A.
    Maffi, Paola
    Posselt, Andrew
    Stock, Peter G.
    Kaufman, Dixon B.
    Luo, Xunrong
    Kandeel, Fouad
    Cagliero, Enrico
    Turgeon, Nicole A.
    Witkowski, Piotr
    Naji, Ali
    O'Connell, Philip J.
    Greenbaum, Carla
    Kudva, Yogish C.
    Brayman, Kenneth L.
    Aull, Meredith J.
    Larsen, Christian
    Kay, Tom W. H.
    Fernandez, Luis A.
    Vantyghem, Marie-Christine
    Bellin, Melena
    Shapiro, A. M. James
    [J]. DIABETES CARE, 2012, 35 (07) : 1436 - 1445
  • [10] Berebichez-Fridman Roberto, 2018, Sultan Qaboos Univ Med J, V18, pe264, DOI 10.18295/squmj.2018.18.03.002